The chemokine CX3CL1/fractalkine interferes with the antinociceptive effect induced by opioid agonists in the periaqueductal grey of rats

Brain Research

Volumn 1153, Issue 1, 2007, Pages 52-57

  Chen, Xiaohong ^a   Geller, Ellen B ^a   Rogers, Thomas J ^a   Adler, Martin W ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antinociception; Chemokine; CX3CL1 fractalkine; Opioid agonist; Periaqueductal grey; Rat

Indexed keywords

CHEMOKINE CX3CL1; DELTA OPIATE RECEPTOR; DYNORPHIN; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; FRACTALKINE; KAPPA OPIATE RECEPTOR; MU OPIATE RECEPTOR; OPIATE AGONIST; RANTES; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; MALE; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; RAT;

ANALGESICS, OPIOID; ANALYSIS OF VARIANCE; ANIMALS; CHEMOKINE CX3CL1; DRUG INTERACTIONS; DYNORPHINS; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ENKEPHALIN, D-PENICILLAMINE (2,5)-; MALE; PAIN MEASUREMENT; PERIAQUEDUCTAL GRAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID;

RATTUS;

EID: 34248997169     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.03.066     Document Type: Article

References (41)

1. Adams J.U., Bussiere J.L., Geller E.B., and Adler M.W. Pyrogenic doses of intracerebroventricular interleukin-1 did not induce analgesia in the rat hot-plate or cold-water tail-flick tests. Life Sci. 53 (1993) 1401-1409
2. Adams J.U., Geller E.B., and Adler M.W. Receptor selectivity of icv morphine in the rat cold water tail-flick test. Drug Alcohol Depend. 35 (1994) 197-202
3. Adler M.W., Geller E.B., Chen X.H., and Rogers T.J. Viewing chemokines as a third major system of communication in the brain. AAPS J. 7 (2006) E865-E870
4. Adler M.W., and Geller E.B. Physiological functions of opioids: temperature regulation. In: Opioids II, Herz A., Akil H., and Simon E.J. (Eds). Handbook of Experimental Pharmacology vol. 104/II (1993), Springer-Verlag, Berlin 205-238
5. Basbaum A.I., and Fields H.L. Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Annu. Rev. Neurosci. 7 (1984) 309-338
6. Boddeke H.W.G.M., Meigel I., Frentzel S., Biber K., Renn L.Q., and Gebicke-Harter P. Functional expression of the fractalkine (CX3C) receptor and its regulation by lipopolysaccharide in rat microglia. Eur. J. Pharmacol. 374 (1999) 309-313
7. Chen X., Geller E.B., Rogers T.J., and Adler M.W. Rapid heterologous desensitization of antinociceptive activity between mu or delta opioid receptors and chemokine receptors in rats. Drug Alcohol Depend. 88 (2007) 36-41
8. Chen X.H., Adams J.U., Geller E.B., DeRiel J.K., Adler M.W., and Liu-Chen L.-Y. An antisense oligodeoxynucleotide to μ-opioid receptors inhibits μ-agonist-induced analgesia in rats. Eur. J. Pharmacol. 275 (1995) 105-108
9. Damas J.K., Boullier A., Waehre T., Smith C., Sandberg W.J., Green S., Aukrust P., and Quehenberger O. Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, is elevated in coronary artery disease and is reduced during statin therapy. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 2567-2572
10. Goldstein A., Tachibana S., Lowney L.I., Hunkapiller M., and Hood L. Dynorphin-(1-13), an extraordinarily potent opioid peptide. Proc. Natl. Acad. Sci. U. S. A. 76 (1979) 6666-6670
11. Grimm M.C., Ben-Baruch A., Taub D.D., Howard O.M., Resau J.H., Wang J.M., Ali H., Richardson R., Snyderman R., and Oppenheim J.J. Opiates transdeactivate chemokine receptors: delta and mu opiate receptor-mediated heterologous desensitization. J. Exp. Med. 188 (1998) 317-325
12. Handa B.K., Lane A.C., Lord J.A.H., Morgan B.A., Rance M.J., and Smith C.F.C. Analogues of beta-LPH61-64 possessing selective agonist activity at mu-opiate receptors. Eur. J. Pharmacol. 70 (1981) 531-540
13. Harrison J.K., Jiang Y., Chen S., Xia Y., Maciejewski D., McNamara R.K., Streit W.J., Salafranca M.N., Adhikari S., Thompson D.A., Botti P., Bacon K.B., and Feng L. Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 10896-10901
14. Haskell C.A., Cleary M.D., and Charo I.F. Molecular uncoupling of fractalkine-mediated cell adhesion and signal transduction. J. Biol. Chem. 274 (1999) 10053-10058
15. Homan J.W., Steele A.D., Martinand-Mari C., Rogers T.J., Henderson E.E., Charubala R., Pfleiderer W., Reichenbach N.L., and Suhadolnik R.J. Inhibition of morphine-potentiated HIV-1 replication in peripheral blood mononuclear cells with the nuclease-resistant 2-5A agonist analog, 2-5AN6B. J. Acquir. Immune Defic. Syndr. 30 (2002) 9-20
16. Imai T., Hieshima K., Haskell C., Baba M., Nagira M., Nishimura M., Kakizaki M., Takagi S., Nomiyama H., Schall T.J., and Yoshie O. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 91 (1997) 521-530
17. Johnston I.N., Milligan E.D., Wiesler-Frank J., Frank M.G., Zapata V., Campisi J., Langer S., Martin D., Green P., Fleshner M., Leinwand L., and Maier S.F. A role for proinflammatory cytokines and fractalkine in analgesia, tolerance, and subsequent pain facilitation induced by chronic intrathecal morphine. J. Neurosci. 24 (2004) 9353-9365
18. Lindia J.A., McGowan E., Jochnowitz N., and Abbadie C. Induction of CX3CL1 expression in astrocytes and CX3CR1 in microglia in the spinal cord of a rat model of neuropathic pain. J. Pain 6 (2005) 434-438
19. Lokensgard J.R., Gekker G., and Peterson P.K. Kappa-opioid receptor agonist inhibition of HIV-1 envelope glycoprotein-mediated membrane fusion and CXCR4 expression on CD4(+) lymphocytes. Biochem. Pharmacol. 63 (2002) 1037-1041
20. Meucci O., Fatatis A., Simen A.A., Bushell T.J., Gray P.W., and Miller R.J. Chemokines regulate hippocampal neuronal signalling and gp120 neurotoxicity. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 14500-14505
21. Meucci O., Fatatis A., Simen A.A., Bushell T.J., and Miller R.J. Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 8075-8080
22. Milligan E.D., Zapata V., Chacur M., Schoeniger D., Biedenkapp J., O'Connor K.A., Verge G.M., Chapman G., Green P., Foster A.C., Naeve G.S., Maier S.F., and Watkins L.R. Evidence that exogenous and endogenous fractalkine can induce spinal nociceptive facilitation in rats. Eur. J. Neurosci. 20 (2004) 2294-2302
23. Milligan E., Zapata V., Schoeniger D., Chacur M., Green P., Poole S., Martin D., Maier S.F., and Watkins L.R. An initial investigation of spinal mechanisms underlying pain enhancement induced by fractalkine, a neuronally released chemokine. Eur. J. Neurosci. 22 (2005) 2775-2782
24. Mosberg H.I., Hurst R., Hruby V.J., Gee K., Yamamura H.I., Galligan J.J., and Burks T.F. Bis-penicillamine enkephalins possess highly improved specificity towards _ opioid receptors. Proc. Natl. Acad. Sci. U. S. A. 80 (1983) 5871-5874
25. Murphy P.M., Baggiolini M., Charo I.F., Hebert C.A., Horuk R., Matsushima K., Miller L.H., Oppenheim J.J., and Power C.A. International union of pharmacology: XXII. Nomenclature for chemokine receptors. Pharmacol. Rev. 52 (2000) 145-176
26. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates. fourth ed. (1998), Academic Press, San Diego
27. Pizziketti R.J., Pressman N.S., Geller E.B., Cowan A., and Adler M.W. Rat cold water tail-flick: a novel analgesic test that distinguishes opioid agonists from mixed agonist-antagonists. Eur. J. Pharmacol. 119 (1985) 23-29
28. Rogers T.J., and Peterson P.K. Opioid G protein-coupled receptors: signals at the crossroads of inflammation. Trends Immunol. 24 (2003) 116-121
29. Rogers T.J., Steele A.D., Howard O.M.Z., and Oppenheim J.J. Bidirectional heterologous desensitization of opioid and chemokine receptors. Ann. N. Y. Acad. Sci. 917 (2000) 19-28
30. Shavit Y., Wolf G., Goshen I., Livshits D., and Yirmiya R. Interleukin-1 antagonizes morphine analgesia and underlies morphine tolerance. Pain 115 (2005) 50-59
31. Sheng W.S., Hu S., Lokensgard J.R., and Peterson P.K. U50,488 inhibits HIV-1 tat-induced monocyte chemoattractant protein-1 (CCL2) production by human astrocytes. Biochem. Pharmacol. 65 (2003) 9-14
32. Steele A.D., Szabo I., Bednar F., and Rodgers T.J. Interactions between opioid and chemokine receptors: heterologous desensitization. Cytokine Growth Factor Rev. 13 (2002) 209-222
33. Suzuki S., Chuang L.F., Yau P., Doi R.H., and Chuang R.Y. Interactions of opioid and chemokine receptors: oligomerization of mu, kappa, and delta with CCR5 on immune cells. Exp. Cell Res. 280 (2002) 192-200
34. Szabo I., and Rogers T.J. Crosstalk between chemokine and opioid receptors results in downmodulation of cell migration. In: Friedman H., Klein T.W., and Madden J.J. (Eds). Neuroimmune Circuits, Drugs of Abuse, and Infectious Diseases (2001) 75-79
35. Szabo I., Wetzel M.A., McCarthy L., Steele A.D., Henderson E.E., Howard O.M.Z., Oppenheim J.J., and Rogers T.J. Interactions of opioid receptors, chemokines, and chemokine receptors. In: Friedman H., Klein T.W., and Madden J.J. (Eds). Neuroimmune Circuits, Drugs of Abuse, and Infectious Diseases (2001) 69-74
36. Szabo I., Chen X.H., Xin L., Adler M.W., Howard O.M.Z., Oppenheim J.J., and Rogers T.J. Heterologous desensitization of opioid receptors by chemokines inhibits chemotaxis and enhances the perception of pain. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 10276-10281
37. Verge G.M., Milligan E.D., Maier S.F., Watkins L.R., Naeve G.S., and Foster A.C. Fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditions. Eur. J. Neurosci. 20 (2004) 1150-1160
38. Watkins L.R., Hutchinson M.R., Johnston I.N., and Maier S.F. Glia: novel counter-regulators of opioid analgesia. Trends Neurosci. 28 (2005) 661-669
39. Xin L., Geller E.B., and Adler M.W. Body temperature and analgesic effects of selective mu and kappa opioid receptor agonists microdialyzed into rat brain. J. Pharmacol. Exp. Ther. 281 (1997) 499-507
40. Zhang L., and Rogers T.J. K-opioid regulation of thymocyte IL-7 receptor and C-C chemokine receptor 2 expression. J. Immunol. 164 (2000) 5088-5093
41. Zhang N., Rogers T.J., Caterina M., and Oppenheim J.J. Proinflammatory chemokines, such as C-C chemokine ligand 3, desensitize μ-opioid receptors on dorsal root ganglia neurons. J. Immunol. 173 (2004) 594-599